Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Piraterie- und Bedrohungsabwehrexperten von Verimatrix stellen neueste Innovationen auf CABSAT und TT CS vor: https://mms.businesswire.com/media/20200603005395/en/795668/5/VMX+logo+4210606c.jpg
Piraterie- und Bedrohungsabwehrexperten von Verimatrix stellen neueste Innovationen auf CABSAT und TT CS vor


Verimatrix, (Euronext Paris: VMX), der führende Anbieter von Sicherheitslösungen für die moderne vernetzte Welt, die den Menschen in den Mittelpunkt stellen, hat heute die Teilnahme an zwei

Verimatrix Anti-Piracy and Threat Defense Experts To Highlight Latest Innovations at CABSAT and TT CS: https://mms.businesswire.com/media/20200603005395/en/795668/5/VMX+logo+4210606c.jpg
Verimatrix Anti-Piracy and Threat Defense Experts To Highlight Latest Innovations at CABSAT and TT CS


Regulatory News:



Verimatrix, (Euronext Paris: VMX), the leader in powering the modern connected world with people-centered security, today announced participation in two leading conferences this

Freelance.com: Q1 2022 revenue: €181.5m
Freelance.com: Q1 2022 revenue: €181.5m
Freelance.com: Q1 2022 revenue: €181.5m
Kaufman & Broad SA: COMBINED ORDINARY AND EXTRAORDINARY SHAREHOLDERS’ MEETING MAY 5, 2022
Kaufman & Broad SA: COMBINED ORDINARY AND EXTRAORDINARY SHAREHOLDERS’ MEETING MAY 5, 2022
Kaufman & Broad SA: COMBINED ORDINARY AND EXTRAORDINARY SHAREHOLDERS’ MEETING MAY 5, 2022
MYHOTELMATCH: Authorisation of the Commercial Court to postpone the General Meeting
MYHOTELMATCH: Authorisation of the Commercial Court to postpone the General Meeting
MYHOTELMATCH: Authorisation of the Commercial Court to postpone the General Meeting
Poxel Announces Notice of Its Annual General Meeting to Be Held on June 21, 2022: https://mms.businesswire.com/media/20210929005940/en/578635/5/POXEL_LOGO_Q.jpg
Poxel Announces Notice of Its Annual General Meeting to Be Held on June 21, 2022


POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including

Verbesserungen bei Verimatrix Key Shield optimieren SoftPOS-Sicherheitsimplementierungen und stärken Bedrohungsabwehr: https://mms.businesswire.com/media/20200603005395/en/795668/5/VMX+logo+4210606c.jpg
Verbesserungen bei Verimatrix Key Shield optimieren SoftPOS-Sicherheitsimplementierungen und stärken Bedrohungsabwehr


Verimatrix, (Euronext Paris: VMX) (Paris:VMX), der führende Anbieter von kundenorientierten Sicherheitslösungen für die moderne vernetzte Welt, gab heute bekannt, dass Verimatrix Key Shield – das

Eutelsat Communications: Third Quarter and Nine-month 2021-22 Revenues: https://mms.businesswire.com/media/20191112005524/en/397236/5/Eutelsat_Communications_logo.jpg
Eutelsat Communications: Third Quarter and Nine-month 2021-22 Revenues


Regulatory News:



Eutelsat Communications (ISIN: FR0010221234 - Euronext Paris: ETL) (Paris:ETL) reports revenues for the Third Quarter and Nine Months ended 31 March 2022.


In € millions

Verimatrix Key Shield Enhancements Streamline SoftPOS Security Implementations and Bolster Threat Defenses: https://mms.businesswire.com/media/20200603005395/en/795668/5/VMX+logo+4210606c.jpg
Verimatrix Key Shield Enhancements Streamline SoftPOS Security Implementations and Bolster Threat Defenses


Regulatory News:



Verimatrix, (Euronext Paris: VMX) (Paris:VMX), the leader in powering the modern connected world with people-centered security, today announced that Verimatrix Key Shield, its

Sensorion to Attend the American Society of Gene & Cell Therapy (ASGCT) and Gene Therapy Analytical Development Conferences in May 2022: https://mms.businesswire.com/media/20210609005851/en/705797/5/logo-sensorion2.jpg
Sensorion to Attend the American Society of Gene & Cell Therapy (ASGCT) and Gene Therapy Analytical Development Conferences in May 2022


Regulatory News:



Sensorion (FR0012596468 – ALSEN) (Paris:ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and

NANOBIOTIX to Participate in Two Upcoming Investor Conferences: https://mms.businesswire.com/media/20191111005579/en/744572/5/LOGO_NANO_EXPANDING_LIFE.jpg
NANOBIOTIX to Participate in Two Upcoming Investor Conferences


Regulatory News:



NANOBIOTIX (Euronext : NANO –– NASDAQ: NBTX – the "Company"), a clinical-stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for

BALYO gibt die Verlängerung seines Partnerschaftsvertrags mit der KION Group um weitere vier Jahre bekannt
BALYO gibt die Verlängerung seines Partnerschaftsvertrags mit der KION Group um weitere vier Jahre bekannt


BALYO (FR0013258399, Tickersymbol: BALYO, PEA-PME-qualifiziert), Technologieführer im Bereich Konzeption und Entwicklung innovativer Roboterlösungen für Flurförderzeuge, gibt die Verlängerung

BALYO Announces the Renewal of Its Cooperation Agreement With the KION Group for the Next 4 Years
BALYO Announces the Renewal of Its Cooperation Agreement With the KION Group for the Next 4 Years


Regulatory News:



BALYO (FR0013258399, Ticker: BALYO, eligible for PEA-PME savings schemes), a technological leader in the design and development of innovative robotic solutions for material

The GAUSSIN Group and Its European Distributor BLYYD Announce That the ATM 38T FULL ELEC Has Passed the One Million Kilometer Mark
The GAUSSIN Group and Its European Distributor BLYYD Announce That the ATM 38T FULL ELEC Has Passed the One Million Kilometer Mark


GAUSSIN (EURONEXT GROWTH ALGAU - FR0013495298), a pioneer in the clean and intelligent transport of goods and people, announces that its ATM 38T FULL ELEC vehicle, dedicated to logistics, has

Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company’s Share Capital: https://mms.businesswire.com/media/20191111005579/en/744572/5/LOGO_NANO_EXPANDING_LIFE.jpg
Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company’s Share Capital


Regulatory News:



Nanobiotix (Paris:NANO) (NASDAQ:NBTX):



Market: Euronext Paris / Nasdaq
Euronext Compartment: B
ISIN code: FR0011341205
Nasdaq: NBTX
Bloomberg: NANO:FP
Reuters: NANO.PA
Website

Transgene: Q1 2022 Financial Position and Business Update: https://mms.businesswire.com/media/20191209005543/en/255636/5/logo_TRANSGENE.jpg
Transgene: Q1 2022 Financial Position and Business Update


Regulatory News:



Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announces its business update for the

Voyageurs du Monde acquires 'Eurofun Group', the European leader in bike travel
Voyageurs du Monde acquires 'Eurofun Group', the European leader in bike travel
Voyageurs du Monde acquires 'Eurofun Group', the European leader in bike travel
BILENDI: Q1 2022 revenues: €13.4 million,  up +52% (+13.7% on a pro forma basis)
BILENDI: Q1 2022 revenues: €13.4 million, up +52% (+13.7% on a pro forma basis)
BILENDI: Q1 2022 revenues: €13.4 million, up +52% (+13.7% on a pro forma basis)
Eutelsat’s EUTELSAT 172B selected by Tuvalu Telecommunications Corporation to deliver state-of-the-art connectivity to Tuvalu : https://mms.businesswire.com/media/20191112005524/en/397236/5/Eutelsat_Communications_logo.jpg
Eutelsat’s EUTELSAT 172B selected by Tuvalu Telecommunications Corporation to deliver state-of-the-art connectivity to Tuvalu


Regulatory News:



Eutelsat Communications (Euronext Paris: ETL) and The Tuvalu Telecommunications Corporation (TTC) have signed a contract for capacity on EUTELSAT 172B satellite to support the

Sensorion Provides Preliminary Documents for the Combined Shareholders’ General Meeting of May 31, 2022: https://mms.businesswire.com/media/20210609005851/en/705797/5/logo-sensorion2.jpg
Sensorion Provides Preliminary Documents for the Combined Shareholders’ General Meeting of May 31, 2022


Regulatory News:



Sensorion (Paris:ALSEN) (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and

RUBIS:  Release of the preparatory documents to the 9 June 2022 Combined Shareholders' Meeting
RUBIS: Release of the preparatory documents to the 9 June 2022 Combined Shareholders' Meeting
RUBIS: Release of the preparatory documents to the 9 June 2022 Combined Shareholders' Meeting
Kaufman & Broad SA: DESCRIPTION OF THE SHARE REPURCHASE PROGRAM 2021
Kaufman & Broad SA: DESCRIPTION OF THE SHARE REPURCHASE PROGRAM 2021
Kaufman & Broad SA: DESCRIPTION OF THE SHARE REPURCHASE PROGRAM 2021
Median Technologies Is Moving Forward With the FDA Interactions for Its iBiopsy® Lung Cancer Screening CADe/CADx Software as Medical Device: https://mms.businesswire.com/media/20200113005579/en/767035/5/Median_strapline.jpg
Median Technologies Is Moving Forward With the FDA Interactions for Its iBiopsy® Lung Cancer Screening CADe/CADx Software as Medical Device


Regulatory News:



Median Technologies (ALMDT) announces today that the company has received feedback from the United States Food and Drug Administration (FDA) regarding the 513(g) submission done

RUBIS: Q1 2022 trading update – Excellent volume (+10% yoy) and gross profit (+7% yoy) development
RUBIS: Q1 2022 trading update – Excellent volume (+10% yoy) and gross profit (+7% yoy) development
RUBIS: Q1 2022 trading update – Excellent volume (+10% yoy) and gross profit (+7% yoy) development
Kaufman & Broad SA: ORDINARY AND EXTRAORDINARY  SHAREHOLDERS’MEETING ON MAY 5TH, 2022
Kaufman & Broad SA: ORDINARY AND EXTRAORDINARY SHAREHOLDERS’MEETING ON MAY 5TH, 2022
Kaufman & Broad SA: ORDINARY AND EXTRAORDINARY SHAREHOLDERS’MEETING ON MAY 5TH, 2022